XM does not provide services to residents of the United States of America.
R
R

RECSilicon

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Italy's Recordati hikes 2024 guidance after core profit rises 11.5%

Italy's Recordati hikes 2024 guidance after core profit rises 11.5% July 30 (Reuters) - Italian drug maker Recordati RECI.MI raised its guidance for 2024 on Tuesday buoyed by positive momentum in its mainline Specialty and Primary Care and Rare Disease segments and an 11.5% rise in first-half core profit. The Milan-based company raised its earnings before interest, taxes, depreciation and amortization (EBITDA) forecast to between 845 million and 865 million euros ($915-$937 million) from a range
R

Recordati H1 EBITDA EUR 452.9 Mln

BRIEF-Recordati H1 EBITDA EUR 452.9 Mln July 30 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI : SEES 2024 EBITDA IN RANGE OF EUR 845-865 MILLION, EBITDA MARGIN AROUND 24.5% H1 REVENUE EUR 1.2 BILLION H1 ADJUSTED NET PROFIT EUR 301.0 MILLION H1 EBITDA EUR 452.9 MILLION SEES 2024 ADJUSTED NET PROFIT BETWEEN EUR 560 AND 580 MILLIO
R

Italy - Factors to watch on July 30

Italy - Factors to watch on July 30 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Chinese President Xi Jinping and Italian Prime Minister Giorgia Meloni discussed the war in Ukraine and the crisis in the Middle East at a meeting in Beijing on Monday, Meloni's office said.
A
B
E
H
I
L
R
A
D
D
F
I
P
I
U

Italy - Factors to watch on July 9

Italy - Factors to watch on July 9 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury to sell up to 8.5 billion euros in bonds at July 11 auction .
A
A
B
E
I
L
P
R
A
I
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Liberty Global, Crest Nicholson, NCR Voyix and Baxter International July 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2 000 GMT on Friday: * * Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's BAX.N kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters.
B
B
B
C
G
H
R
S
T
U
B
T

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.